JP2023524573A5 - - Google Patents
Info
- Publication number
- JP2023524573A5 JP2023524573A5 JP2022567557A JP2022567557A JP2023524573A5 JP 2023524573 A5 JP2023524573 A5 JP 2023524573A5 JP 2022567557 A JP2022567557 A JP 2022567557A JP 2022567557 A JP2022567557 A JP 2022567557A JP 2023524573 A5 JP2023524573 A5 JP 2023524573A5
- Authority
- JP
- Japan
- Prior art keywords
- domain antibody
- cov
- sars
- coronavirus
- antibody according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2006589.2A GB202006589D0 (en) | 2020-05-04 | 2020-05-04 | Single domain antibodies |
| GB2006589.2 | 2020-05-04 | ||
| GBGB2010861.9A GB202010861D0 (en) | 2020-07-14 | 2020-07-14 | Single domain antibodies |
| GB2010861.9 | 2020-07-14 | ||
| PCT/GB2021/051069 WO2021224606A1 (en) | 2020-05-04 | 2021-05-04 | Single domain antibodies binding to sars-cov-2 spike protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023524573A JP2023524573A (ja) | 2023-06-12 |
| JP2023524573A5 true JP2023524573A5 (https=) | 2024-05-02 |
Family
ID=75977769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022567557A Withdrawn JP2023524573A (ja) | 2020-05-04 | 2021-05-04 | Ｓａｒｓ－ｃｏｖ－２スパイクタンパク質に結合する単一ドメイン抗体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230348572A1 (https=) |
| EP (1) | EP4146689A1 (https=) |
| JP (1) | JP2023524573A (https=) |
| KR (1) | KR20230150184A (https=) |
| AU (1) | AU2021269176A1 (https=) |
| CA (1) | CA3177766A1 (https=) |
| WO (1) | WO2021224606A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023104933A1 (en) * | 2021-12-07 | 2023-06-15 | new/era/mabs GmbH | Camelid antibodies for use in therapy and diagnosis |
| EP4194054A1 (en) * | 2021-12-07 | 2023-06-14 | new/era/mabs GmbH | Camelid antibodies for use in therapy and diagnosis |
| CN114478757B (zh) * | 2022-03-31 | 2022-07-05 | 深圳市人民医院 | 靶向新冠病毒的纳米抗体及其制备方法和应用 |
| CN114736293B (zh) * | 2022-06-14 | 2022-09-02 | 中国农业科学院生物技术研究所 | SARS-CoV-2中和性纳米抗体、自组装铁蛋白融合纳米抗体及制备方法和应用 |
| WO2025147701A1 (en) * | 2024-01-07 | 2025-07-10 | Abalone Bio, Inc. | Cannabinoid receptor type 2 antibodies and uses thereof |
| WO2026006639A1 (en) * | 2024-06-26 | 2026-01-02 | Rutgers, The State University Of New Jersey | Antigen binding molecules targeting transferrin receptor 1 |
| GB202413879D0 (en) | 2024-09-20 | 2024-11-06 | Rosalind Franklin Inst | Single domain antibodies |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111333722A (zh) | 2020-03-03 | 2020-06-26 | 江苏省疾病预防控制中心(江苏省公共卫生研究院) | SARS-CoV-2抑制剂及其应用 |
| CN114163523B (zh) | 2020-03-17 | 2023-07-18 | 北京凯因科技股份有限公司 | 一种针对新型冠状病毒的单域抗体及其应用 |
| CN111647076B (zh) | 2020-04-27 | 2021-02-26 | 南京医科大学 | 抗新型冠状病毒SARS-Cov-2的中和性单域抗体及其应用 |
-
2021
- 2021-05-04 AU AU2021269176A patent/AU2021269176A1/en not_active Abandoned
- 2021-05-04 CA CA3177766A patent/CA3177766A1/en active Pending
- 2021-05-04 KR KR1020227041509A patent/KR20230150184A/ko active Pending
- 2021-05-04 JP JP2022567557A patent/JP2023524573A/ja not_active Withdrawn
- 2021-05-04 WO PCT/GB2021/051069 patent/WO2021224606A1/en not_active Ceased
- 2021-05-04 EP EP21726440.7A patent/EP4146689A1/en not_active Withdrawn
- 2021-05-04 US US17/923,142 patent/US20230348572A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023524573A5 (https=) | ||
| CN111961133A (zh) | 一种针对新冠病毒SARS-CoV-2棘突蛋白非RBD区的单克隆抗体及其应用 | |
| Baumgartner et al. | Developmental expression of claudins in the mammary gland | |
| JP2023542107A5 (https=) | ||
| CN116769023B (zh) | 鼠抗马尔尼菲篮状菌甘露聚糖蛋白杂交瘤细胞株，单克隆抗体及应用 | |
| WO2021233433A1 (zh) | 抗SARS-CoV-2刺突蛋白单克隆抗体 | |
| CN104497142B (zh) | Cp4‑epsps蛋白的单克隆抗体 | |
| CN108486069A (zh) | 一种猪流行性腹泻病毒低含量样品的病毒分离方法 | |
| US20230029322A1 (en) | Tools and methods to detect and isolate colibactin producing bacteria | |
| CN110476065A (zh) | 诊断法 | |
| CN100523173C (zh) | 一种检测猪产毒多杀性巴氏杆菌毒素抗体的elisa试剂盒及应用 | |
| WO2016023514A1 (zh) | 预防猪鼻支原体感染细胞的方法及制剂 | |
| Herrera et al. | The Streptococcus pyogenes fibronectin/tenascin-binding protein PrtF. 2 contributes to virulence in an influenza superinfection | |
| CN119613542A (zh) | 人高尔基体膜蛋白gp73的抗体6g12、抗体组合物及应用 | |
| TW202041523A (zh) | 一種類風溼關節炎自體抗體結合的胜肽及其應用 | |
| JP7414225B2 (ja) | ＳＡＲＳ－ＣｏＶ－２結合ペプチド | |
| CN115850457A (zh) | 一种靶向冠状病毒rbd蛋白的抗体 | |
| CN115894675A (zh) | 新冠病毒SARS-CoV-2核衣壳蛋白单克隆抗体及其应用 | |
| CN116621974A (zh) | 新型冠状病毒SARS-CoV-2广谱中和纳米抗体及其应用 | |
| KR20190036291A (ko) | Nckap1 단백질 또는 상기 단백질을 암호화하는 유전자를 포함하는 신경계 퇴행성질환의 예방 또는 치료용 약학적 조성물 | |
| CN121379976B (zh) | 抗TcdA毒素杂交瘤细胞株、单克隆抗体及应用 | |
| CN121379975B (zh) | 抗TcdB毒素杂交瘤细胞株、单克隆抗体及应用 | |
| CN119912574B (zh) | 靶向ERα36的鲨鱼单域抗体及其制备方法、应用 | |
| CN114773463B (zh) | 一种针对新冠病毒omicron株S蛋白的单域抗体VHH-1及编码序列和应用 | |
| US10155008B2 (en) | Use of 15 male fertility related proteins or combination thereof |